Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer.

Keerthi GogineniKevin Kalinsky
Published in: JCO oncology practice (2022)